Aspirin and decreased adult-onset asthma: Randomized comparisons from the physicians' health study

American Journal of Respiratory and Critical Care Medicine

Volumn 175, Issue 2, 2007, Pages 120-125

  Barr, R Graham ^b   Kurth, Tobias ^a   Stampfer, Meir J ^b   Buring, Julie E ^b   Hennekens, Charles H ^b   Gaziano, J Michael ^b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b NONE

Author keywords

Analgesics; Aspirin; Asthma; NSAIDs; Obstructive airways disease

Indexed keywords

ACETYLSALICYLIC ACID;

ADULT; AGED; ARTICLE; ASTHMA; BODY MASS; CARDIOVASCULAR RISK; CIGARETTE SMOKING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG TOLERANCE; DRUG USE; FOLLOW UP; GENERAL PRACTITIONER; HEALTH SURVEY; HEART INFARCTION; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; ONSET AGE; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SELF REPORT;

ADULT; AGED; AGED, 80 AND OVER; ASPIRIN; ASTHMA; FEMALE; HUMANS; MALE; MIDDLE AGED; PHYSICIANS; QUESTIONNAIRES; RISK; UNITED STATES;

EID: 33846305056     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.200603-411OC     Document Type: Article

References (35)

1. Vollmer WM, Osborne ML, Buist AS. 20-year trends in the prevalence of asthma and chronic airflow obstruction in an HMO. Am J Respir Crit Care Med 1998;157:1079-1084.
2. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. Lancet 1998;351:1225-1232.
3. Varner AE, Busse WW, Lemanske RFJ. Hypothesis: decreasing use of pediatric aspirin has contributed to the increasing prevalence of childhood asthma. Ann Allergy Asthma Immunol 1998;81:347-351.
4. Halpin TJ, Holtzhauer FJ, Campbell RJ, Hall LJ, Correa-Villasenor A, Lanese R, Rice J, Hurwitz ES. Reye's syndrome and medication use. JAMA 1982;248:687-691.
5. Waldman RJ, Hall WN, McGee H, Van Amburg G. Aspirin as a risk factor in Reye's syndrome. JAMA 1982;247:3089-3094.
6. Perez GM, Melo M, Keegan AD, Zamorano J. Aspirin and salicylates inhibit the IL-4- and IL-13-induced activation of STAT6. J Immunol 2002;168:1428-1434.
7. Chen LC, Kepka-Lenhart D, Wright TM, Morris SM Jr. Salicylate-enhanced activation of transcription factors induced by interferon-gamma. Biochem J 1999;342:503-507.
8. Barr RG, Wentowski CC, Curhan GC, Somers SC, Stampfer MJ, Schwartz J, Speizer FE, Camargo CA Jr. Prospective study of acetaminophen use and risk of newly diagnosed asthma among women. Am J Respir Crit Care Med 2004;169:836-841.
9. Barr RG, Kurth T, Stampfer MJ, Hennekens CH, Gaziano JM. Low dose aspirin and decreased adult-onset asthma: randomized comparisons from the Physicians' Health Study. Eur Respir J 2005;26:681s.
10. Steering Committee of the Physicians' Health Study Research Group. Final report on the aspirin component of the ongoing Physicians' Health Study. N Engl J Med 1989;321:129-135.
11. Christen WG, Gaziano JM, Hennekens CH. Design of Physicians' Health Study II: a randomized trial of beta-carotene, vitamins E and C, and multivitamins, in prevention of cancer, cardiovascular disease, and eye disease, and review of results of completed trials. Ann Epidemiol 2000;10:125-134.
12. Cox D. Regression models and life-tables. J R Stat Soc Ser B 1972;34:187-220.
13. McKeever TM, Lewis SA, Smit HA, Burney P, Britton JR, Cassano PA. The association of acetaminophen, aspirin, and ibuprofen with respiratory disease and lung function. Am J Respir Crit Care Med 2005;171:966-971.
14. Lesko SM, Mitchell AA. The safety of acetaminophen and ibuprofen among children younger than two years old. Pediatrics 1999;104:e39.
15. Lesko SM, Louik C, Vezina RM, Mitchell AA. Asthma morbidity after the short-term use of ibuprofen in children. Pediatrics 2002;109:e20.
16. Kasper L, Sladek K, Duplaga M, Bochenek G, Liebhart J, Gladysz U, Malolepszy J, Szczeklik A. Prevalence of asthma with aspirin hypersensitivity in the adult population of Poland. Allergy 2003;58:1064-1066.
17. Hedman J, Kapiro J, Poussa T, Nieminen MM. Prevalence of asthma, aspirin intolerance, nasal polyposis and chronic obstructive pulmonary disease in a population-based study. Int J Epidemiol 1999;28:717-722.
18. Vally H, Taylor ML, Thompson PJ. The prevalence of aspirin intolerant asthma (AIA) in Australian asthmatic patients. Thorax 2002;57:569-574.
19. Jenkins C, Costello J, Hodge L. Systematic review of prevalence of aspirin induced asthma and its implications for clinical practice. BMJ 2004;328:434.
20. Szczeklik A, Sanak M, Nizankowska-Mogilnicka E, Kielbasa B. Aspirin intolerance and the cyclooxygenase-leukotriene pathways. Curr Opin Pulm Med 2004;10:51-56.
21. Park JS, Chang HS, Park CS, Lee JH, Lee YM, Choi JH, Park HS, Kim LH, Park BL, Choi YH, et al. Association analysis of cysteinyl-leukotriene receptor 2 (CYSLTR2) polymorphisms with aspirin intolerance in asthmatics. Pharmacogenet Genomics 2005;15:483-492.
22. Kim SH, Choi JH, Park HS, Holloway JW, Lee SK, Park CS, Shin HD. Association of thromboxane A2 receptor gene polymorphism with the phenotype of acetyl salicylic acid-intolerant asthma. Clin Exp Allergy 2005;35:585-590.
23. Jinnai N, Sakagami T, Sekigawa T, Kakihara M, Nakajima T, Yoshida K, Goto S, Hasegawa T, Koshino T, Hasegawa Y, et al. Polymorphisms in the prostaglandin E2 receptor subtype 2 gene confer susceptibility to aspirin-intolerant asthma: a candidate gene approach. Hum Mol Genet 2004;13:3203-3217.
24. Szczeklik A, Gryglewski RJ, Nizankowska E. Asthma relieved by aspirin and by other cyclo-oxygenase inhibitors. Thorax 1978;33:664-665.
25. Kordansky D, Adkinson NF Jr, Norman PS, Rosenthal RR. Asthma improved by nonsteroidal anti-inflammatory drugs. Ann Intern Med 1978;88:508-511.
26. Resta O, Foschino-Barbaro MP, Carnimeo N, Bavoso P, Picca V. Asthma relieved by acetylsalicylic acid and nonsteroid anti-inflammatory drugs. Respiration (Herrlisheim) 1984;46:121-127.
27. Pang L, Pitt A, Petkova D, Knox AJ. The COX-1/COX-2 balance in asthma. Clin Exp Allergy 1998;28:1050-1058.
28. Betz M, Fox BS. Prostaglandin E2 inhibits production of TH1 lymphokines but not TH2 lymphokines. J Immunol 1991;146:108-113.
29. Snijdewint FGM, Kalinski P, Wierenga EA, Bos JD, Kapsenberg ML. Prostaglandin E2 differentially modulates cytokine secretion profiles of human T helper lymphocytes. J Immunol 1993;150:5321-5329.
30. Kopp E, Ghosh S. Inhibition of NF-kappa B by sodium salicylate and aspirin. Science 1994;265:956-959.
31. Fiorucci S, Santucci L, Wallace JL, Sardina M, Romano M, del Soldato P, Morelli A. Interaction of a selective cyclooxygenase-2 inhibitor with aspirin and NO-releasing aspirin in the human gastric mucosa. Proc Natl Acad Sci USA 2003;100:10937-10941.
32. Levy BD, De Sanctis GT, Devchand PR, Kim E, Ackerman K, Schmidt BA, Szczeklik W, Drazen JM, Serhan CN. Multi-pronged inhibition of airway hyper-responsiveness and inflammation by lipoxin A(4). Nat Med 2002;8:1018-1023.
33. Bonnans C, Vachier I, Chavis C, Godard P, Bousquet J, Chanez P. Lipoxins are potential endogenous antiinflammatory mediators in asthma. Am J Respir Crit Care Med 2002;165:1531-1535.
34. Barr RG, Herbstman J, Speizer FE, Camargo CA Jr. Validation of self-reported chronic obstructive pulmonary disease in a cohort study of nurses. Am J Epidemiol 2002;155:965-971.
35. Kurth T, Gaziano JM. Cumulative analgesic use and risk of incident asthma in men [abstract]. Pharmacoepidemiol Drug Saf 2005;14:S134.